tiprankstipranks
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market
CMPX
Compass Therapeutics
RESEARCH TOOLSreports
Want to see CMPX full AI Analyst Report?

Compass Therapeutics (CMPX) Income Statement

530 Followers

Compass Therapeutics Income Statement

Last quarter (Q4 2025), Compass Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Compass Therapeutics's net income was $-15.72M. See Compass Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 850.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 850.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 72.84M$ 57.48M$ 50.36M$ 41.66M$ 81.88M
Depreciation and Amortization
$ 0.00$ 1.75M$ 1.89M$ 1.90M$ 1.62M
EBITDA
$ -72.84M$ -54.87M$ -48.47M$ -39.75M$ -80.19M
Operating Income
$ -72.84M$ -56.63M$ -50.36M$ -41.66M$ -81.88M
Other Income/Expenses
$ 6.35M$ 7.25M$ 7.87M$ 2.43M$ -299.00K
Pretax Income
$ -66.49M$ -49.38M$ -42.49M$ -39.23M$ -82.18M
Net Income
$ -66.49M$ -49.38M$ -42.49M$ -39.23M$ -82.18M
Per Share Metrics
Basic EPS
$ -0.42$ -0.36$ -0.33$ -0.35$ -1.31
Diluted EPS
$ -0.42$ -0.36$ -0.33$ -0.35$ -1.31
Weighted Average Shares Outstanding
 157.69M 137.11M 127.03M 105.19M 62.87M
Weighted Average Shares Outstanding (Diluted)
 157.69M 137.11M 127.03M 105.19M 62.87M
Currency in USD

Compass Therapeutics Earnings and Revenue History